Kalexsyn
From Wikipedia, the free encyclopedia
| Kalexsyn, Inc. | |
|---|---|
 |
|
| Type | Private |
| Founded | Kalamazoo, Michigan, USA (July 18, 2003) |
| Headquarters |  Kalamazoo, Michigan, USA |
| Key people | Robert C. Gadwood, President & Chief Scientific Officer David C. Zimmermann, CEO |
| Industry | Contract Research Organization Pharmaceutical |
| Products | drug development services synthetic organic chemistry |
| Revenue | $2.8 million USD (2006) |
| Employees | 23 (March, 2007) |
| Website | www.kalexsyn.com |
Kalexsyn, Inc. is a contract life sciences company in Kalamazoo, Michigan. Kalexsyn was formed in 2003 by two former employees of Pharmacia whose jobs were eliminated when that company was purchased by Pfizer. The company name is a contraction of the phrase "Kalamazoo Experts in Synthesis."
On March 29, 2007, Kalexsyn broke ground on a new 20,000 square foot, $4.5 million building in southwest Kalamazoo.
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
